Works matching IS 00071188 AND DT 2013 AND VI 169 AND IP 8

Results: 23

Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.

Published in:

2013

By:

Ferrandi, Mara;
Barassi, Paolo;
Tadini-Buoninsegni, Francesco;
Bartolommei, Gianluca;
Molinari, Isabella;
Tripodi, Maria Grazia;
Reina, Cristina;
Moncelli, Maria Rosa;
Bianchi, Giuseppe;
Ferrari, Patrizia

Publication type:

journal article

Inosine induces presynaptic inhibition of acetylcholine release by activation of A3 adenosine receptors at the mouse neuromuscular junction.

Published in:

2013

By:

Cinalli, A R;
Guarracino, J F;
Fernandez, V;
Roquel, L I;
Losavio, A S

Publication type:

journal article

The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.

Published in:

2013

By:

Slawinska, Anna;
Wieronska, Joanna M;
Stachowicz, Katarzyna;
Marciniak, Marcin;
Lason-Tyburkiewicz, Magdalena;
Gruca, Piotr;
Papp, Mariusz;
Kusek, Magdalena;
Tokarski, Krzysztof;
Doller, Darío;
Pilc, Andrzej;
Sławińska, Anna;
Wierońska, Joanna M;
Lasoń-Tyburkiewicz, Magdalena

Publication type:

journal article

A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Published in:

2013

By:

Kalappa, Bopanna I;
Sun, Fen;
Johnson, Stephen R;
Jin, Kunlin;
Uteshev, Victor V

Publication type:

journal article

The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.

Published in:

2013

By:

Liu, Zhen;
Han, Yi;
Li, Ling;
Lu, Hui;
Meng, Guoliang;
Li, Xiaozhen;
Shirhan, Mohammed;
Peh, Meng Teng;
Xie, Liping;
Zhou, Suming;
Wang, Xiaowei;
Chen, Qi;
Dai, Weilu;
Tan, Choon-Hong;
Pan, Shiyang;
Moore, Philip K;
Ji, Yong

Publication type:

journal article

YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.

Published in:

2013

By:

Xu, Youzhi;
Lin, Hongjun;
Meng, Nana;
Lu, Wenjie;
Li, Guobo;
Han, Yuanyuan;
Dai, Xiaoyun;
Xia, Yong;
Song, Xiangrong;
Yang, Shengyong;
Wei, Yuquan;
Yu, Luoting;
Zhao, Yinglan

Publication type:

journal article

Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Published in:

2013

By:

Aggarwal, Bharat B;
Gupta, Subash C;
Sung, Bokyung

Publication type:

journal article

Issue Information.

Published in:: British Journal of Pharmacology, 2013, v. 169, n. 8, p. i, doi. 10.1111/j.1476-5381.2012.02163.x
Publication type:: Article

Inosine induces presynaptic inhibition of acetylcholine release by activation of A3 adenosine receptors at the mouse neuromuscular junction.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1810, doi. 10.1111/bph.12262

By:

Cinalli, A R;
Guarracino, J F;
Fernandez, V;
Roquel, L I;
Losavio, A S

Publication type:

Article

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1745, doi. 10.1111/bph.12244

By:

Curtin, N J

Publication type:

Article

The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate m Glu4 receptors in rodents.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1824, doi. 10.1111/bph.12254

By:

Sławińska, Anna;
Wierońska, Joanna M;
Stachowicz, Katarzyna;
Marciniak, Marcin;
Łasoń ‐ Tyburkiewicz, Magdalena;
Gruca, Piotr;
Papp, Mariusz;
Kusek, Magdalena;
Tokarski, Krzysztof;
Doller, Darío;
Pilc, Andrzej

Publication type:

Article

Targeting survival pathways in chronic myeloid leukaemia stem cells.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1693, doi. 10.1111/bph.12183

By:

Sinclair, A;
Latif, A L;
Holyoake, T L

Publication type:

Article

That which does not kill me makes me stronger; combining ERK1/2 pathway inhibitors and BH3 mimetics to kill tumour cells and prevent acquired resistance.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1708, doi. 10.1111/bph.12220

By:

Sale, Matthew J;
Cook, Simon J

Publication type:

Article

To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1652, doi. 10.1111/bph.12253

By:

Piccoli, C;
Agriesti, F;
Scrima, R;
Falzetti, F;
Di Ianni, M;
Capitanio, N

Publication type:

Article

Functional and morphological characterization of glutamate transporters in the rat locus coeruleus.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1781, doi. 10.1111/bph.12235

By:

Medrano, M C;
Gerrikagoitia, I;
Martínez ‐ Millán, L;
Mendiguren, A;
Pineda, J

Publication type:

Article

The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E−/− mice.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1795, doi. 10.1111/bph.12246

By:

Liu, Zhen;
Han, Yi;
Li, Ling;
Lu, Hui;
Meng, Guoliang;
Li, Xiaozhen;
Shirhan, Mohammed;
Peh, Meng Teng;
Xie, Liping;
Zhou, Suming;
Wang, Xiaowei;
Chen, Qi;
Dai, Weilu;
Tan, Choon ‐ Hong;
Pan, Shiyang;
Moore, Philip K;
Ji, Yong

Publication type:

Article

A positive allosteric modulator of α7 n AChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1862, doi. 10.1111/bph.12247

By:

Kalappa, Bopanna I;
Sun, Fen;
Johnson, Stephen R;
Jin, Kunlin;
Uteshev, Victor V

Publication type:

Article

Emerging therapeutic aspects in oncology.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1647, doi. 10.1111/bph.12304

By:

MacEwan, David J

Publication type:

Article

Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1840, doi. 10.1111/bph.12252

By:

Andrag, Ellen;
Curtis, Michael J

Publication type:

Article

Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1672, doi. 10.1111/bph.12131

By:

Aggarwal, Bharat B;
Gupta, Subash C;
Sung, Bokyung

Publication type:

Article

Death receptors as targets in cancer.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1723, doi. 10.1111/bph.12238

By:

Micheau, O;
Shirley, S;
Dufour, F

Publication type:

Article

Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1849, doi. 10.1111/bph.12278

By:

Ferrandi, Mara;
Barassi, Paolo;
Tadini ‐ Buoninsegni, Francesco;
Bartolommei, Gianluca;
Molinari, Isabella;
Tripodi, Maria Grazia;
Reina, Cristina;
Moncelli, Maria Rosa;
Bianchi, Giuseppe;
Ferrari, Patrizia

Publication type:

Article

YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 8, p. 1766, doi. 10.1111/bph.12216

By:

Xu, Youzhi;
Lin, Hongjun;
Meng, Nana;
Lu, Wenjie;
Li, Guobo;
Han, Yuanyuan;
Dai, Xiaoyun;
Xia, Yong;
Song, Xiangrong;
Yang, Shengyong;
Wei, Yuquan;
Yu, Luoting;
Zhao, Yinglan

Publication type:

Article

Works matching IS 00071188 AND DT 2013 AND VI 169 AND IP 8

Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.

Inosine induces presynaptic inhibition of acetylcholine release by activation of A3 adenosine receptors at the mouse neuromuscular junction.

The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.

A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.

YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.

Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Issue Information.

Inosine induces presynaptic inhibition of acetylcholine release by activation of A<sub>3</sub> adenosine receptors at the mouse neuromuscular junction.

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate m Glu<sub>4</sub> receptors in rodents.

Targeting survival pathways in chronic myeloid leukaemia stem cells.

That which does not kill me makes me stronger; combining ERK1/2 pathway inhibitors and BH3 mimetics to kill tumour cells and prevent acquired resistance.

To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Functional and morphological characterization of glutamate transporters in the rat locus coeruleus.

The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E<sup>−/−</sup> mice.

A positive allosteric modulator of α7 n AChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Emerging therapeutic aspects in oncology.

Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Death receptors as targets in cancer.

Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.

YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.